Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 5/20 | 0.54 |
| ▸ | LGALS9 | O00182 | 4/20 | 0.54 |
| ▸ | LGALS1 | P09382 | 4/20 | 0.54 |
| ▸ | LGALS7; LGALS7B | P47929 | 3/20 | 0.54 |
| ▸ | SELP | P16109 | 7/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.41 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.40 |
| ▸ | SELE | P16581 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16256917 | 0.88 | LGALS3 (0.53) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP | |
| SCHEMBL12139431 | 0.88 | LGALS3 (0.44) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL26269274 | 0.88 | LGALS3 (0.44) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL10005361 | 0.88 | LGALS3 (0.44) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL14586559 | 0.88 | LGALS3 (0.44) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL15815859 | 0.87 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP | |
| SCHEMBL17318202 | 0.87 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP | |
| SCHEMBL7221498 | 0.87 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP | |
| SCHEMBL4954660 | 0.87 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP | |
| SCHEMBL4534423 | 0.87 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7321029-B2 | High RNA binding affinity to complementary nucleic acids and are base and acid stable; treatment of cancer, viral infections | GERON CORPORATION (US) | 2008-01-22 | — | — | US | disclosed |